Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Serum Albumin in Large Acute Ischemic Stroke After Thrombectomy
NCT06629116Recruiting
- Sponsor
- Tingyu-Yi
- Start
- Jan 2024
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of albumin (human) in ischemic stroke (2 arms), sponsored by Tingyu-Yi. Primary endpoint: Functional Independence Rate at 3 months. Started Jan 2024; status: recruiting.
02
Drugs
albumin (human)
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06629116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06629116.